Identifying tumor-specific cancer treatments using patient-derived tumor organoids
We speak with Dr. Benjamin Hopkins to learn how his team is pairing comprehensive genomics with drug screening of high-fidelity patient-derived organoids to help identify effective therapeutic strategies for cancer patients.